 CLEVELAND, Jan. 11, 2022 GLOBE NEWSWIRE -- Sotera Health Company Sotera Health or the Company NASDAQ: SHC, a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today is providing an update on the Companys accomplishments and key growth drivers, as well as the current market dynamics related to its businesses. At the 40th Annual J.P. Morgan Healthcare Conference, Chairman and Chief Executive Officer Michael B. Petras, Jr. will highlight Sotera Healths long-term organic and inorganic growth roadmap, addressable markets, and its environmental, social and governance ESG program. 